Answers are grounded in this paper and cite their sources.
These data suggest that increased uPAR expression and uPA activity induced by anti-Ro60 binding to the apoptotic fetal cardiocyte provide a molecular basis by which these antibodies inhibit efferocytosis and ultimately lead to scar of the fetal conduction system and working myocardium.
No takes yet. Share an insight, caveat, or question.
Briassouli et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: